Molecular Imaging and the PD-L1 Pathway: From Bench to Clinic

Programmed death-1 (PD-1) and programmed death ligand 1 (PD-L1) inhibitors target the important molecular interplay between PD-1 and PD-L1, a key pathway contributing to immune evasion in the tumor microenvironment (TME). Long-term clinical benefit has been observed in patients receiving PD-(L)1 inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Leung, David, Bonacorsi, Samuel, Smith, Ralph Adam, Weber, Wolfgang, Hayes, Wendy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420047/
https://www.ncbi.nlm.nih.gov/pubmed/34497758
http://dx.doi.org/10.3389/fonc.2021.698425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420047/
https://www.ncbi.nlm.nih.gov/pubmed/34497758
http://dx.doi.org/10.3389/fonc.2021.698425

Ejemplares similares